Cumulative incidence of leukemia (including myelodysplastic syndromes, myeloproliferative neoplasms, acute myeloid leukemia, chronic myeloid leukemia, and chronic lymphocytic leukemia) among patients who had detectable mosaic chromosomal alterations (mCA) only, gene mutation putative driver (PD) only, both, or neither; 95% CIs are shown in shaded ribbons. From Figure 4c. Gao T, Ptashkin R, Bolton KL et al. Nat Commun 2021;12:338. Licensed under Creative Commons Attribution 4.0 International License; http://creativecommons.org/licenses/by/4.0/.